Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
作者:
主题词
老年人(Aged);心血管药物(Cardiovascular Agents);卡方分布(Chi-Square Distribution);冠状血管造影术(Coronary Angiography);冠状动脉疾病(Coronary Artery Disease);糖尿病, 1型(Diabetes Mellitus, Type 1);糖尿病, 2型(Diabetes Mellitus, Type 2);糖尿病血管病变(Diabetic Angiopathies);药物洗脱支架(Drug-Eluting Stents);女(雌)性(Female);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);肾功能衰竭, 慢性(Kidney Failure, Chronic);Logistic模型(Logistic Models);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);心肌梗死(Myocardial Infarction);病人遴选(Patient Selection);倾向性评分(Propensity Score);比例危险度模型(Proportional Hazards Models);假体设计(Prosthesis Design);登记(Registries);韩国(Republic of Korea);危险因素(Risk Factors);西罗莫司(Sirolimus);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1016/j.jcin.2013.12.201
PMID
24852802
发布时间
2020-12-16
- 浏览48
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文